BHVN
Stifel Financial’s Biohaven Pharmaceutical Holding Company Ltd. BHVN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-3,071,644
| Closed | -$464M | – | 3449 |
|
|
2022
Q3 | $464M | Sell |
3,071,644
-195
| -0% | -$29.5K | 0.76% | 21 |
|
|
2022
Q2 | $448M | Buy |
3,071,839
+23,771
| +0.8% | +$3.46M | 0.7% | 20 |
|
|
2022
Q1 | $361M | Sell |
3,048,068
-1,927
| -0.1% | -$228K | 0.49% | 41 |
|
|
2021
Q4 | $420M | Buy |
3,049,995
+55,650
| +2% | +$7.67M | 0.56% | 36 |
|
|
2021
Q3 | $416M | Buy |
2,994,345
+424,304
| +17% | +$58.9M | 0.61% | 32 |
|
|
2021
Q2 | $249M | Buy |
2,570,041
+5,219
| +0.2% | +$507K | 0.37% | 66 |
|
|
2021
Q1 | $175M | Buy |
2,564,822
+22,348
| +0.9% | +$1.53M | 0.29% | 88 |
|
|
2020
Q4 | $218M | Buy |
2,542,474
+14,431
| +0.6% | +$1.24M | 0.39% | 64 |
|
|
2020
Q3 | $164M | Buy |
2,528,043
+36,957
| +1% | +$2.4M | 0.34% | 81 |
|
|
2020
Q2 | $182M | Sell |
2,491,086
-347,460
| -12% | -$25.4M | 0.42% | 63 |
|
|
2020
Q1 | $96.6M | Buy |
2,838,546
+1,500
| +0.1% | +$51K | 0.27% | 101 |
|
|
2019
Q4 | $154M | Hold |
2,837,046
| – | – | 0.32% | 82 |
|
|
2019
Q3 | $118M | Sell |
2,837,046
-1,492
| -0.1% | -$62.2K | 0.3% | 77 |
|
|
2019
Q2 | $124M | Buy |
2,838,538
+11,500
| +0.4% | +$504K | 0.32% | 73 |
|
|
2019
Q1 | $146M | Buy |
2,827,038
+107,500
| +4% | +$5.53M | 0.41% | 51 |
|
|
2018
Q4 | $101M | Buy |
2,719,538
+2,304,438
| +555% | +$85.2M | 0.33% | 73 |
|
|
2018
Q3 | $15.6M | Hold |
415,100
| – | – | 0.04% | 369 |
|
|
2018
Q2 | $16.4M | Hold |
415,100
| – | – | 0.05% | 369 |
|
|
2018
Q1 | $10.7M | Sell |
415,100
-200
| -0% | -$5.15K | 0.03% | 513 |
|
|
2017
Q4 | $11.2M | Hold |
415,300
| – | – | 0.04% | 485 |
|
|
2017
Q3 | $15.5M | Buy |
415,300
+100
| +0% | +$3.74K | 0.05% | 348 |
|
|
2017
Q2 | $10.4M | Buy |
+415,200
| New | +$10.4M | 0.04% | 458 |
|